Annual Shareholders Equity
$116.74 M
+$1.04 M+0.90%
31 December 2023
Summary:
Black Diamond Therapeutics annual stockholders equity is currently $116.74 million, with the most recent change of +$1.04 million (+0.90%) on 31 December 2023. During the last 3 years, it has fallen by -$191.02 million (-62.07%). BDTX annual shareholders equity is now -62.07% below its all-time high of $307.76 million, reached on 31 December 2020.BDTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$97.43 M
-$13.60 M-12.25%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly stockholders equity is currently $97.43 million, with the most recent change of -$13.60 million (-12.25%) on 30 September 2024. Over the past year, it has dropped by -$36.89 million (-27.47%). BDTX quarterly shareholders equity is now -72.58% below its all-time high of $355.26 million, reached on 31 March 2020.BDTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.9% | -27.5% |
| 3 y3 years | -62.1% | -55.5% |
| 5 y5 years | +851.1% | +28.1% |
BDTX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.1% | +0.9% | -55.5% | +18.5% |
| 5 y | 5 years | -62.1% | +347.6% | -72.6% | +306.6% |
| alltime | all time | -62.1% | +347.6% | -72.6% | +306.6% |
Black Diamond Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $97.43 M(-12.2%) |
| June 2024 | - | $111.02 M(+6.4%) |
| Mar 2024 | - | $104.31 M(-10.6%) |
| Dec 2023 | $116.74 M(+0.9%) | $116.74 M(-13.1%) |
| Sept 2023 | - | $134.32 M(+63.4%) |
| June 2023 | - | $82.20 M(-16.3%) |
| Mar 2023 | - | $98.19 M(-15.1%) |
| Dec 2022 | $115.69 M(-40.9%) | $115.69 M(-13.2%) |
| Sept 2022 | - | $133.23 M(-12.6%) |
| June 2022 | - | $152.37 M(-11.7%) |
| Mar 2022 | - | $172.56 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $195.90 M(-36.3%) | $195.90 M(-10.5%) |
| Sept 2021 | - | $218.95 M(-12.8%) |
| June 2021 | - | $251.02 M(-10.6%) |
| Mar 2021 | - | $280.75 M(-8.8%) |
| Dec 2020 | $307.76 M(-752.6%) | $307.76 M(-6.0%) |
| Sept 2020 | - | $327.35 M(-4.6%) |
| June 2020 | - | $343.13 M(-3.4%) |
| Mar 2020 | - | $355.26 M(-853.4%) |
| Dec 2019 | -$47.16 M(+203.4%) | -$47.16 M(-162.0%) |
| Sept 2019 | - | $76.09 M(-589.6%) |
| Dec 2018 | -$15.54 M(+132.8%) | -$15.54 M |
| Dec 2017 | -$6.67 M | - |
FAQ
- What is Black Diamond Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual shareholders equity year-on-year change?
- What is Black Diamond Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?
What is Black Diamond Therapeutics annual stockholders equity?
The current annual shareholders equity of BDTX is $116.74 M
What is the all time high annual shareholders equity for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual stockholders equity is $307.76 M
What is Black Diamond Therapeutics annual shareholders equity year-on-year change?
Over the past year, BDTX annual stockholders equity has changed by +$1.04 M (+0.90%)
What is Black Diamond Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BDTX is $97.43 M
What is the all time high quarterly shareholders equity for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly stockholders equity is $355.26 M
What is Black Diamond Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, BDTX quarterly stockholders equity has changed by -$36.89 M (-27.47%)